Targeting autophagy in cardiac ischemia/reperfusion injury: A novel therapeutic strategy

Aghaei, M. and Motallebnezhad, M. and Ghorghanlu, S. and Jabbari, A. and Enayati, A. and Rajaei, M. and Pourabouk, M. and Moradi, A. and Alizadeh, A.M. and Khori, V. (2019) Targeting autophagy in cardiac ischemia/reperfusion injury: A novel therapeutic strategy. Journal of Cellular Physiology.

Full text not available from this repository.
Official URL:


Acute myocardial infarction (AMI) is one of the leading causes of morbidity worldwide. Myocardial reperfusion is known as an effective therapeutic choice against AMI. However, reperfusion of blood flow induces ischemia/reperfusion (I/R) injury through different complex processes including ion accumulation, disruption of mitochondrial membrane potential, the formation of reactive oxygen species, and so forth. One of the processes that gets activated in response to I/R injury is autophagy. Indeed, autophagy acts as a �double-edged sword� in the pathology of myocardial I/R injury and there is a controversy about autophagy being beneficial or detrimental. On the basis of the autophagy effect and regulation on myocardial I/R injury, many studies targeted it as a therapeutic strategy. In this review, we discuss the role of autophagy in I/R injury and its targeting as a therapeutic strategy. © 2019 Wiley Periodicals, Inc.

Item Type: Article
Additional Information: cited By 0
Subjects: WG Cardiovascular System
Depositing User: eprints admin
Date Deposited: 13 Oct 2020 06:08
Last Modified: 13 Oct 2020 06:08

Actions (login required)

View Item View Item